
Stealth BioTherapeutics Corp – NASDAQ:MITO
Stealth BioTherapeutics Corp stock price today
Stealth BioTherapeutics Corp stock price monthly change
Stealth BioTherapeutics Corp stock price quarterly change
Stealth BioTherapeutics Corp stock price yearly change
Stealth BioTherapeutics Corp key metrics
Market Cap | N/A |
Enterprise value | N/A |
P/E | -0.34 |
EV/Sales | N/A |
EV/EBITDA | 0.01 |
Price/Sales | N/A |
Price/Book | -0.36 |
PEG ratio | -0.06 |
EPS | -0.95 |
Revenue | N/A |
EBITDA | -51.49M |
Income | -54.28M |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | 0% |
Oper. margin | 0% |
Gross margin | 0% |
EBIT margin | 0% |
EBITDA margin | N/A |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeStealth BioTherapeutics Corp stock price history
Stealth BioTherapeutics Corp stock forecast
Stealth BioTherapeutics Corp financial statements
Jun 2021 | 0 | -18.40M | |
---|---|---|---|
Sep 2021 | 0 | -6.29M | |
Dec 2021 | 0 | -26.92M | |
Mar 2022 | 0 | -2.65M |
2022-05-18 | -0.02 | -0.01 |
---|
Jun 2021 | 32258000 | 58.57M | 181.58% |
---|---|---|---|
Sep 2021 | 44187000 | 73.01M | 165.25% |
Dec 2021 | 50226000 | 95.52M | 190.18% |
Mar 2022 | 36915000 | 89.23M | 241.72% |
Jun 2020 | 0 | 0 | 0 |
---|---|---|---|
Sep 2020 | 0 | 0 | 0 |
Dec 2020 | -9.71M | -20K | 22.63M |
Dec 2021 | -35.25M | 203K | 36.50M |
Stealth BioTherapeutics Corp alternative data
Aug 2023 | 38 |
---|---|
Sep 2023 | 38 |
Oct 2023 | 38 |
Nov 2023 | 38 |
Dec 2023 | 38 |
Jan 2024 | 38 |
Feb 2024 | 38 |
Mar 2024 | 38 |
Apr 2024 | 38 |
May 2024 | 38 |
Jun 2024 | 38 |
Jul 2024 | 38 |
Stealth BioTherapeutics Corp other data
Patent |
---|
Grant Filling date: 2 Dec 2019 Issue date: 8 Mar 2022 |
Application Filling date: 19 Nov 2019 Issue date: 10 Feb 2022 |
Application Filling date: 9 Jul 2021 Issue date: 30 Dec 2021 |
Application Filling date: 16 Apr 2021 Issue date: 30 Dec 2021 |
Application Filling date: 15 Jul 2019 Issue date: 28 Oct 2021 |
Application COMPOSITIONS AND METHODS FOR THE PREVENTION AND/OR TREATMENT OF MITOCHONDRIAL DISEASE, INCLUDING FRIEDREICH'S ATAXIA Filling date: 2 Apr 2021 Issue date: 14 Oct 2021 |
Grant Utility: Therapeutic compositions including frataxin, lactoferrin, and mitochondrial energy generating enzymes, and uses thereof Filling date: 17 Jan 2020 Issue date: 12 Oct 2021 |
Application Filling date: 8 Apr 2021 Issue date: 23 Sep 2021 |
Grant Filling date: 15 Jul 2020 Issue date: 10 Aug 2021 |
Grant Filling date: 19 Jun 2017 Issue date: 10 Aug 2021 |
Quarter | Transcript |
---|---|
Q3 2021 11 Nov 2021 | Q3 2021 Earnings Call Transcript |
Q2 2021 7 Aug 2021 | Q2 2021 Earnings Call Transcript |
Q1 2021 18 May 2021 | Q1 2021 Earnings Call Transcript |
Q4 2020 6 Apr 2021 | Q4 2020 Earnings Call Transcript |
-
What's the price of Stealth BioTherapeutics Corp stock today?
One share of Stealth BioTherapeutics Corp stock can currently be purchased for approximately $0.32.
-
When is Stealth BioTherapeutics Corp's next earnings date?
Unfortunately, Stealth BioTherapeutics Corp's (MITO) next earnings date is currently unknown.
-
Does Stealth BioTherapeutics Corp pay dividends?
No, Stealth BioTherapeutics Corp does not pay dividends.
-
What is Stealth BioTherapeutics Corp's stock symbol?
Stealth BioTherapeutics Corp is traded on the NASDAQ under the ticker symbol "MITO".
-
What is Stealth BioTherapeutics Corp's primary industry?
Company operates in the Healthcare sector and Biotechnology industry.
-
How do i buy shares of Stealth BioTherapeutics Corp?
Shares of Stealth BioTherapeutics Corp can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
How many employees does Stealth BioTherapeutics Corp have?
As Jul 2024, Stealth BioTherapeutics Corp employs 38 workers.
-
When Stealth BioTherapeutics Corp went public?
Stealth BioTherapeutics Corp is publicly traded company for more then 6 years since IPO on 15 Feb 2019.
-
What is Stealth BioTherapeutics Corp's official website?
The official website for Stealth BioTherapeutics Corp is stealthbt.com.
-
Where are Stealth BioTherapeutics Corp's headquarters?
Stealth BioTherapeutics Corp is headquartered at 190 Elgin Avenue, George Town, GEORGE TOWN, GRAND CAYMAN.
-
How can i contact Stealth BioTherapeutics Corp?
Stealth BioTherapeutics Corp's mailing address is 190 Elgin Avenue, George Town, GEORGE TOWN, GRAND CAYMAN and company can be reached via phone at +61 76006888.
Stealth BioTherapeutics Corp company profile:

Stealth BioTherapeutics Corp
stealthbt.comNASDAQ
38
Biotechnology
Healthcare
Stealth BioTherapeutics Corp, a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of therapies for diseases involving mitochondrial dysfunction. Its lead product candidate is Elamipretide that is in phase 3 clinical trial to treat barth syndrome, phase 2/3 clinical trial for the treatment of duchenne cardiomyopathy, phase 2a clinical trial to treat friedreich's ataxia, phase 2 clinical trial for the treatment of dry age-related macular degeneration, phase 2 clinical trial to treat leber's hereditary optic neuropathy, and phase 3 clinical trial for the treatment of replisome myopathies. The company's product candidates also include SBT-20 to treat complications of diabetes, renal diseases, ocular diseases, neurodegenerative, Parkinson's, Alzheimer's, Huntington's, and ALS diseases; SBT-550 for rare neurological indications; and SBT-272, a peptidomimetic that targets the mitochondria and stabilizing mitochondrial function under conditions of oxidative stress, as well as SBT 550. Stealth BioTherapeutics Corp was incorporated in 2006 and is based in George Town, the Cayman Islands.
GEORGE TOWN, GRAND CAYMAN KY1-9005
CIK: 0001696396
ISIN: US85789A1051
CUSIP: 85789A105